LINC02237

Across TCGA pan-cancer cohorts, LINC02237 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC02237 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher LINC02237 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02237 expression acts as an unfavorable survival marker, although some lineages such as THCA and LGG show a favorable association.

THCA, LGG, and CESC are the cancer types where LINC02237 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Median	II,III,IV	0.930	0.777	<.001	57	view →
LGG	DFS	Tertile	All	0.824	0.661	<.001	39	view →
CESC	DFS	Tertile	III,IV	0.190	0.727	.006	36	view →
SKCM	DFS	Quartile	IV	0.082	0.565	.014	18	view →
UCEC	OS	Tertile	III,IV	0.658	0.837	.017	18	view →
STAD	DFS	Tertile	All	0.564	0.692	.005	16	view →
ACC	DFS	Quartile	All	0.162	0.758	.014	16	view →
TGCT	DFS	Median	All	0.923	0.743	.007	14	view →
THYM	DFS	Tertile	All	1.000	0.715	.024	9	view →
BLCA	DFS	Tertile	III,IV	0.188	0.392	.042	9	view →
UVM	DFS	Tertile	All	1.000	0.493	.049	6	view →
READ	OS	Tertile	All	0.535	0.855	.011	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC02237–THCA (DFS)

Open the THCA breakdown →